Home > Insider Trading > Filing (0001288123-15-000015)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Agenus Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380178	Shahzad Malik	Agenus Inc. 3 Forbes Road Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-08	111,289	$3.00	1,107,377	No	4	J	Indirect	see footnote
Common Stock	Disposition	2015-04-28	700,000	$7.16	407,377	No	4	S	Indirect	see footnote
Common Stock	Disposition	2015-04-29	407,377	$7.02	0	No	4	S	Indirect	see footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	see footnote
No	4	S	Indirect	see footnote
No	4	S	Indirect	see footnote

Footnotes

On May 8, 2014, Agenus Inc. issued to Advent Venture Partners LLP ("Advent") and its affiliated entities, and not Dr. Malik in his individual capacity, 111,289 shares of common stock of Agenus Inc., as repayment for certain indebtedness owed by 4-Antibody-AG, a wholly-owned subsidiary of Agenus Inc., to Advent and its affiliated entities as former shareholders of 4-Antibody AG prior to Agenus Inc.'s acquisition of 4-Antibody AG in February 2014. Dr. Malik is a GP of Advent Venture Partners LLP and shares voting and investment power of the shares, and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Represents shares sold by Advent Venture Partners LLP and its affiliated entities, and not Dr. Malik in his individual capacity.